KENVUE INC (KVUE) Stock Overview
USA - NYSE:KVUE - US49177J1025 - Common Stock
KVUE Key Statistics, Chart & Performance
The current stock price of KVUE is 16.34 USD. In the past month the price decreased by -21.1%. In the past year, price decreased by -26.26%.
KVUE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 22.33 | 145.08B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 59.42 | 32.08B | ||
| ELF | ELF BEAUTY INC | 41.26 | 7.44B | ||
| BRBR | BELLRING BRANDS INC | 16.94 | 4.63B | ||
| COTY | COTY INC-CL A | 18.23 | 3.50B | ||
| ODD | ODDITY TECH LTD-CL A | 28.64 | 3.41B | ||
| IPAR | INTERPARFUMS INC | 19.58 | 3.22B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.72 | 925.95M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 917.58M | ||
| OLPX | OLAPLEX HOLDINGS INC | 16.63 | 887.22M | ||
| HLF | HERBALIFE LTD | 4.03 | 877.47M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 9.98 | 597.96M |
Related stock screener links
About KVUE
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 22000
Phone: 19088741200
KENVUE INC / KVUE FAQ
What is the stock price of KENVUE INC today?
The current stock price of KVUE is 16.34 USD. The price decreased by -0.49% in the last trading session.
What is the ticker symbol for KENVUE INC stock?
The exchange symbol of KENVUE INC is KVUE and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is KVUE stock listed?
KVUE stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for KENVUE INC stock?
24 analysts have analysed KVUE and the average price target is 22.92 USD. This implies a price increase of 40.28% is expected in the next year compared to the current price of 16.34. Check the KENVUE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is KENVUE INC worth?
KENVUE INC (KVUE) has a market capitalization of 31.36B USD. This makes KVUE a Large Cap stock.
How many employees does KENVUE INC have?
KENVUE INC (KVUE) currently has 22000 employees.
What are the support and resistance levels for KENVUE INC (KVUE) stock?
KENVUE INC (KVUE) has a resistance level at 17.29. Check the full technical report for a detailed analysis of KVUE support and resistance levels.
Is KENVUE INC (KVUE) expected to grow?
The Revenue of KENVUE INC (KVUE) is expected to decline by -2.74% in the next year. Check the estimates tab for more information on the KVUE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy KENVUE INC (KVUE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KVUE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KVUE, evaluating the profitability, health, valuation and growth aspects
- KENVUE INC (KVUE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KENVUE INC (KVUE) Sales and EPS estimates to see what analysts future expectations are.
- KENVUE INC (KVUE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KENVUE INC (KVUE) Insider and Institutional Ownership to learn about the owners and their transactions.
- KENVUE INC (KVUE) Stock Chart to make your own analysis
- KENVUE INC (KVUE) Latest news and press-releases to stay up to date.
Does KENVUE INC (KVUE) stock pay dividends?
KENVUE INC (KVUE) has a dividend yield of 4.92%. The yearly dividend amount is currently 0.81. Check the full fundamental report for a detailed analysis of KVUE dividend history, reliability and sustainability.
When does KENVUE INC (KVUE) report earnings?
KENVUE INC (KVUE) will report earnings on 2025-10-23, before the market open.
What is the Price/Earnings (PE) ratio of KENVUE INC (KVUE)?
The PE ratio for KENVUE INC (KVUE) is 15.27. This is based on the reported non-GAAP earnings per share of 1.07 and the current share price of 16.34 USD. Check the full fundamental report for a full analysis of the valuation metrics for KVUE.
What is the Short Interest ratio of KENVUE INC (KVUE) stock?
The outstanding short interest for KENVUE INC (KVUE) is 2.24% of its float. Check the ownership tab for more information on the KVUE short interest.
KVUE Technical Analysis
KVUE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to KVUE. KVUE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
KVUE Financial Highlights
Over the last trailing twelve months KVUE reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS decreased by -12.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.37% | ||
| ROA | 5.23% | ||
| ROE | 13.22% | ||
| Debt/Equity | 0.73 |
KVUE Forecast & Estimates
24 analysts have analysed KVUE and the average price target is 22.92 USD. This implies a price increase of 40.28% is expected in the next year compared to the current price of 16.34.
For the next year, analysts expect an EPS growth of -7.42% and a revenue growth -2.74% for KVUE